<DOC>
	<DOC>NCT00646321</DOC>
	<brief_summary>The purpose of this study is to compare Symbicort with budesonide alone for the treatment of asthma in children aged 6 to 15 years</brief_summary>
	<brief_title>Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>At least 6 and maximally 15 years of age Diagnosis of asthma and baseline lung function tests as determined by the protocol Has required and received treatment with inhaled corticosteroids within the timeframe and doses specified in the protocol Severe asthma Has required treatment with any noninhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with betablockers</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>children</keyword>
	<keyword>adolescents</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/ formoterol</keyword>
	<keyword>budesonide</keyword>
</DOC>